Clinical trial
Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major…
NCT00237666 · The Medical Research Network, Other · Completed
Key facts
| NCT number | NCT00237666 |
|---|---|
| Title | Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression |
| Official title | An Open-Label, Flexible-Dose Trial of the Safety and Efficacy of Geodon in Non-Rapid-Cycling Bipolar II Patients With Major Depression |
| Lead sponsor | The Medical Research Network, Other |
| Collaborators | Liebowitz, Michael R., M.D. Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar II Disorder, Major Depressive Episode |
| Intervention type | Drug |
| Interventions | Ziprasidone |
| Enrollment | 30 |
| Start date | Feb 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Oct 12, 2005 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: